{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:27:43Z","timestamp":1777699663116,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00393-018-0541-3","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T06:26:32Z","timestamp":1538720792000},"page":"789-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pathogenese des systemischen Lupus erythematodes","Pathogenesis of systemic lupus erythematosus"],"prefix":"10.1007","volume":"77","author":[{"given":"S.","family":"Finzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Voll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"541_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/art.20999","volume":"52","author":"D Alarcon-Segovia","year":"2005","unstructured":"Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 52:1138\u20131147","journal-title":"Arthritis Rheum"},{"key":"541_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/rheumatology\/kep270","volume":"48","author":"M Aringer","year":"2009","unstructured":"Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS (2009) Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology 48:1451\u20131454","journal-title":"Rheumatology"},{"key":"541_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K","volume":"46","author":"I Baumann","year":"2002","unstructured":"Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191\u2013201","journal-title":"Arthritis Rheum"},{"key":"541_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.coi.2012.07.008","volume":"24","author":"PG Bronson","year":"2012","unstructured":"Bronson PG, Chaivorapol C, Ortmann W, Behrens TW, Graham RR (2012) The genetics of type I interferon in systemic lupus erythematosus. Curr Opin Immunol 24:530\u2013537","journal-title":"Curr Opin Immunol"},{"key":"541_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcon GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a\u00a0randomized trial. Ann Intern Med 142:953\u2013962","journal-title":"Ann Intern Med"},{"key":"541_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","volume":"43","author":"P Coit","year":"2013","unstructured":"Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, Merrill JT, McCune WJ, Sawalha AH (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J\u00a0Autoimmun 43:78\u201384","journal-title":"J Autoimmun"},{"key":"541_CR7","first-page":"330","volume":"6","author":"M Cojocaru","year":"2011","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD (2011) Manifestations of systemic lupus erythematosus. Maedica (Buchar) 6:330\u2013336","journal-title":"Maedica (Buchar)"},{"key":"541_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.semarthrit.2015.01.006","volume":"44","author":"J Cortes-Hernandez","year":"2015","unstructured":"Cortes-Hernandez J, Egri N, Vilardell-Tarres M, Ordi-Ros J (2015) Etanercept in refractory lupus arthritis: an observational study. Semin Arthritis Rheum 44:672\u2013679","journal-title":"Semin Arthritis Rheum"},{"key":"541_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.1780350310","volume":"35","author":"D Deapen","year":"1992","unstructured":"Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35:311\u2013318","journal-title":"Arthritis Rheum"},{"key":"541_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s10067-013-2224-4","volume":"32","author":"S Ekblom-Kullberg","year":"2013","unstructured":"Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Julkunen H (2013) Smoking and the risk of systemic lupus erythematosus. Clin Rheumatol 32:1219\u20131222","journal-title":"Clin Rheumatol"},{"key":"541_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/art.39962","volume":"69","author":"R Furie","year":"2017","unstructured":"Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S (2017) Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheumatol 69:376\u2013386","journal-title":"Arthritis Rheumatol"},{"key":"541_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jonsen A, Bengtsson AA, Rantapaa-Dahlqvist S, Baechler EC, Brown EE, Alarcon GS, Edberg JC, Ramsey-Goldman R, McGwin G Jr., Reveille JD, Vila LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, Seldin MF, Ronnblom L, Criswell LA, Syvanen AC, Behrens TW, Graham RR (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41:1228\u20131233","journal-title":"Nat Genet"},{"key":"541_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/ng.200","volume":"40","author":"RR Graham","year":"2008","unstructured":"Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, Burtt NP, Guiducci C, Parkin M, Gates C, Plenge RM, Behrens TW, Wither JE, Rioux JD, Fortin PR, Graham DC, Wong AK, Vyse TJ, Daly MJ, Altshuler D, Moser KL, Gaffney PM (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40:1059\u20131061","journal-title":"Nat Genet"},{"key":"541_CR14","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 107:9813\u20139818","journal-title":"Proc Natl Acad Sci USA"},{"key":"541_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He J, Zhang X, Wei Y, Sun X, Chen Y (2016) Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med 22:991\u2013993","journal-title":"Nat Med."},{"key":"541_CR16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H","volume":"41","author":"M Herrmann","year":"1998","unstructured":"Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241\u20131250","journal-title":"Arthritis Rheum"},{"key":"541_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMoa0707865","volume":"358","author":"G Hom","year":"2008","unstructured":"Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA, Gregersen PK, Behrens TW (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N\u00a0Engl J Med 358:900\u2013909","journal-title":"N Engl J Med"},{"key":"541_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00393-016-0129-8","volume":"75","author":"JY Humrich","year":"2016","unstructured":"Humrich JY, Riemekasten G (2016) IL-2-Therapie beim SLE \u2013 Selektive Rekonstitution immunologischer Toleranz. Z\u00a0Rheumatol 75:490\u2013492","journal-title":"Z Rheumatol"},{"key":"541_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, Fleisher T, Balow JE, Lipsky PE (2010) Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 62:542\u2013552","journal-title":"Arthritis Rheum"},{"key":"541_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.immuni.2015.05.012","volume":"42","author":"C Jacquemin","year":"2015","unstructured":"Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, Maurouard T, Dougall D, Davizon ES, Dumortier H, Douchet I, Raffray L, Richez C, Lazaro E, Duffau P, Truchetet ME, Khoryati L, Mercie P, Couzi L, Merville P, Schaeverbeke T, Viallard JF, Pellegrin JL, Moreau JF, Muller S, Zurawski S, Coffman RL, Pascual V, Ueno H, Blanco P (2015) OX40 Ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity 42:1159\u20131170","journal-title":"Immunity"},{"key":"541_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1196\/annals.1423.031","volume":"1110","author":"LJ Jara","year":"2007","unstructured":"Jara LJ, Cruz-Cruz P, Saavedra MA, Medina G, Garcia-Flores A, Angeles U, Miranda-Limon JM (2007) Bromocriptine during pregnancy in systemic lupus erythematosus: a\u00a0pilot clinical trial. Ann N Y Acad Sci 1110:297\u2013304","journal-title":"Ann N Y Acad Sci"},{"key":"541_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","volume":"65","author":"LJ Jara","year":"2017","unstructured":"Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Torres-Aguilar H, Navarro C, Vazquez Del Mercado M, Espinoza LR (2017) Prolactin has a\u00a0pathogenic role in systemic lupus erythematosus. Immunol Res 65:512\u2013523","journal-title":"Immunol Res"},{"key":"541_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/1735-1995.199089","volume":"22","author":"H Karimzadeh","year":"2017","unstructured":"Karimzadeh H, Shirzadi M, Karimifar M (2017) The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: a randomized clinical trial. J\u00a0Res Med Sci 22:4","journal-title":"J Res Med Sci"},{"key":"541_CR24","doi-asserted-by":"publisher","first-page":"92920","DOI":"10.1172\/jci.insight.92920","volume":"2","author":"D Kienhofer","year":"2017","unstructured":"Kienhofer D, Hahn J, Stoof J, Csepregi JZ, Reinwald C, Urbonaviciute V, Johnsson C, Maueroder C, Podolska MJ, Biermann MH, Leppkes M, Harrer T, Hultqvist M, Olofsson P, Munoz LE, Mocsai A, Herrmann M, Schett G, Holmdahl R, Hoffmann MH (2017) Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight 2:92920","journal-title":"JCI Insight"},{"key":"541_CR25","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/ncomms16021","volume":"8","author":"CD Langefeld","year":"2017","unstructured":"Langefeld CD, Ainsworth HC, Cunninghame GDS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA (2017) Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:16021","journal-title":"Nat Commun."},{"key":"541_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","volume":"7","author":"A Mahajan","year":"2016","unstructured":"Mahajan A, Herrmann M, Munoz LE (2016) Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE. Front Immunol 7:35","journal-title":"Front Immunol"},{"key":"541_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00296-013-2898-6","volume":"34","author":"S Mao","year":"2014","unstructured":"Mao S, Huang S (2014) Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a\u00a0meta-analysis. Rheumatol Int 34:381\u2013388","journal-title":"Rheumatol Int"},{"key":"541_CR28","first-page":"1515","volume":"25","author":"CR Meier","year":"1998","unstructured":"Meier CR, Sturkenboom MC, Cohen AS, Jick H (1998) Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J\u00a0Rheumatol 25:1515\u20131519","journal-title":"J Rheumatol"},{"key":"541_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/art.40360","volume":"70","author":"JT Merrill","year":"2018","unstructured":"Merrill JT, Wallace DJ, Wax S, Kao A, Fraser PA, Chang P, Isenberg D (2018) Efficacy and safety of atacicept in patients with systemic lupus erythematosus: results of a\u00a0twenty-four-week, multicenter, randomized, double-blind, placebo-controlled, parallel-arm, phase IIb study. Arthritis Rheumatol 70:266\u2013276","journal-title":"Arthritis Rheumatol"},{"key":"541_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2016.08.010","volume":"185","author":"P Mistry","year":"2017","unstructured":"Mistry P, Kaplan MJ (2017) Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol 185:59\u201373","journal-title":"Clin Immunol"},{"key":"541_CR31","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s10067-018-4204-1","volume":"37","author":"CC Mok","year":"2018","unstructured":"Mok CC, Bro ET, Ho LY, Singh RJ, Jannetto PJ (2018) Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a\u00a0longitudinal cohort analysis. Clin Rheumatol 37:2685\u20132692. \n                    https:\/\/doi.org\/10.1007\/s10067-018-4204-1","journal-title":"Clin Rheumatol"},{"key":"541_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, Leon MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a\u00a0randomised, placebo-controlled, phase 3 trial. Lancet 377:721\u2013731","journal-title":"Lancet"},{"key":"541_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0162-3109(99)00018-1","volume":"42","author":"JS Navratil","year":"1999","unstructured":"Navratil JS, Korb LC, Ahearn JM (1999) Systemic lupus erythematosus and complement deficiency: clues to a\u00a0novel role for the classical complement pathway in the maintenance of immune tolerance. Immunopharmacology 42:47\u201352","journal-title":"Immunopharmacology"},{"key":"541_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1763","volume":"14","author":"K Neubert","year":"2008","unstructured":"Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE (2008) The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14:748\u2013755","journal-title":"Nat Med"},{"key":"541_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.semnephrol.2015.08.004","volume":"35","author":"HL Pedersen","year":"2015","unstructured":"Pedersen HL, Horvei KD, Thiyagarajan D, Seredkina N, Rekvig OP (2015) Murine and human lupus nephritis: pathogenic mechanisms and theoretical strategies for therapy. Semin Nephrol 35:427\u2013438","journal-title":"Semin Nephrol"},{"key":"541_CR36","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa051135","volume":"353","author":"M Petri","year":"2005","unstructured":"Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N\u00a0Engl J Med 353:2550\u20132558","journal-title":"N Engl J Med"},{"key":"541_CR37","first-page":"1716","volume":"25","author":"P Rahman","year":"1998","unstructured":"Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J\u00a0Rheumatol 25:1716\u20131719","journal-title":"J Rheumatol"},{"key":"541_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5152\/eurjrheum.2017.16059","volume":"4","author":"W Raymond","year":"2017","unstructured":"Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J (2017) IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: evidence for a\u00a0dual role. Eur J Rheumatol 4:29\u201335","journal-title":"Eur J Rheumatol"},{"key":"541_CR39","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/art.39722","volume":"68","author":"BH Rovin","year":"2016","unstructured":"Rovin BH, van Vollenhoven RF, Aranow C, Wagner C, Gordon R, Zhuang Y, Belkowski S, Hsu B (2016) A Multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis. Arthritis Rheumatol 68:2174\u20132183","journal-title":"Arthritis Rheumatol"},{"key":"541_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7326\/0003-4819-122-6-199503150-00005","volume":"122","author":"J Sanchez-Guerrero","year":"1995","unstructured":"Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122:430\u2013433","journal-title":"Ann Intern Med"},{"key":"541_CR41","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/0961203318762598","volume":"27","author":"Y Satoh","year":"2018","unstructured":"Satoh Y, Nakano K, Yoshinari H, Nakayamada S, Iwata S, Kubo S, Miyagawa I, Yoshikawa M, Miyazaki Y, Saito K, Tanaka Y (2018) A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab. Lupus 27:1202\u20131206","journal-title":"Lupus"},{"key":"541_CR42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","volume":"376","author":"M Steri","year":"2017","unstructured":"Steri M, Orru V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faa V, Floris M, Deiana M, Asunis I, Porcu E, Mulas A, Piras MG, Lobina M, Lai S, Marongiu M, Serra V, Marongiu M, Sole G, Busonero F, Maschio A, Cusano R, Cuccuru G, Deidda F, Poddie F, Farina G, Dei M, Virdis F, Olla S, Satta MA, Pani M, Delitala A, Cocco E, Frau J, Coghe G, Lorefice L, Fenu G, Ferrigno P, Ban M, Barizzone N, Leone M, Guerini FR, Piga M, Firinu D, Kockum I, Lima Bomfim I, Olsson T, Alfredsson L, Suarez A, Carreira PE, Castillo-Palma MJ, Marcus JH, Congia M, Angius A, Melis M, Gonzalez A, Alarcon Riquelme ME, da Silva BM, Marchini M, Danieli MG, Del Giacco S, Mathieu A, Pani A, Montgomery SB, Rosati G, Hillert J, Sawcer S, D\u2019Alfonso S, Todd JA, Novembre J, Abecasis GR, Whalen MB, Marrosu MG, Meloni A, Sanna S, Gorospe M, Schlessinger D, Fiorillo E, Zoledziewska M, Cucca F (2017) Overexpression of the cytokine BAFF and autoimmunity risk. N\u00a0Engl J Med 376:1615\u20131626","journal-title":"N Engl J Med"},{"key":"541_CR43","doi-asserted-by":"publisher","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","volume":"7","author":"KE Taylor","year":"2011","unstructured":"Taylor KE, Chung SA, Graham RR, Ortmann WA, Lee AT, Langefeld CD, Jacob CO, Kamboh MI, Alarcon-Riquelme ME, Tsao BP, Moser KL, Gaffney PM, Harley JB, Petri M, Manzi S, Gregersen PK, Behrens TW, Criswell LA (2011) Risk alleles for systemic lupus erythematosus in a\u00a0large case-control collection and associations with clinical subphenotypes. PLoS Genet 7:e1001311","journal-title":"PLoS Genet"},{"key":"541_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/BOR.0000000000000310","volume":"28","author":"M Teruel","year":"2016","unstructured":"Teruel M, Alarcon-Riquelme ME (2016) Genetics of systemic lupus erythematosus and Sjogren\u2019s syndrome: an update. Curr Opin Rheumatol 28:506\u2013514","journal-title":"Curr Opin Rheumatol"},{"key":"541_CR45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","volume":"30","author":"GE Thorlacius","year":"2018","unstructured":"Thorlacius GE, Wahren-Herlenius M, Ronnblom L (2018) An update on the role of type I interferons in systemic lupus erythematosus and Sjogren\u2019s syndrome. Curr Opin Rheumatol 30:471\u2013481. \n                    https:\/\/doi.org\/10.1097\/BOR.0000000000000524","journal-title":"Curr Opin Rheumatol"},{"key":"541_CR46","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J\u00a0Exp Med 205:3007\u20133018","journal-title":"J Exp Med"},{"key":"541_CR47","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1136\/lupus-2018-000288","volume":"5","author":"R Vollenhoven van","year":"2018","unstructured":"van Vollenhoven R, Hahn B, Tsokos G, Wagner C, Lipsky P, Hsu B, Chevrier M, Gordon R, Triebel M, Rose S (2018) S7A:8 Efficacy and safety of ustekinumab, an interleukin 12\/23 inhibitor, in patients with active systemic lupus erythematosus: results of a\u00a0phase 2, randomised placebo-controlled study. Lupus Sci Med 5:A28\u2013A29","journal-title":"Lupus Sci. Med."},{"key":"541_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12016-017-8653-0","volume":"53","author":"F Vanoni","year":"2017","unstructured":"Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD, Bianchetti MG, Bozzini MA, Agostoni C, Milani GP (2017) Neonatal systemic lupus erythematosus syndrome: a\u00a0comprehensive review. Clin Rev Allergy Immunol 53:469\u2013476","journal-title":"Clin Rev Allergy Immunol"},{"key":"541_CR49","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","volume":"75","author":"C Spee-Mayer von","year":"2016","unstructured":"von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, Enghard P, Sawitzki B, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Humrich JY (2016) Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis 75:1407\u20131415","journal-title":"Ann Rheum Dis"},{"key":"541_CR50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius M, Dorner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382:819\u2013831","journal-title":"Lancet"},{"key":"541_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","volume":"392","author":"DJ Wallace","year":"2018","unstructured":"Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dorner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW (2018) Baricitinib for systemic lupus erythematosus: a\u00a0double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 392:222\u2013231","journal-title":"Lancet"},{"key":"541_CR52","first-page":"177","volume":"18","author":"A Watad","year":"2016","unstructured":"Watad A, Neumann SG, Soriano A, Amital H, Shoenfeld Y (2016) Vitamin D and systemic lupus erythematosus: myth or reality? Isr Med Assoc\u00a0J 18:177\u2013182","journal-title":"Isr Med Assoc J"},{"key":"541_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","volume":"127","author":"CK Wong","year":"2008","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127:385\u2013393","journal-title":"Clin Immunol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0541-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T23:21:06Z","timestamp":1570231266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0541-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"5 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Finzel, S.\u00a0Schaffer, M.\u00a0Rizzi und R.E.\u00a0Voll geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}